
- BioPharm International-03-15-2021
- Volume 2021 eBook
- Issue 1
Enabling the Virtual Human Through Physiologically-based Pharmacokinetic Modeling
Basic principles of physiologically-based pharmacokinetic (PBPK) modeling and its impact in streamlining the drug development process are reviewed.
Predictive sciences—built on improved computational capabilities and a deeper understanding of human physiology—are allowing researchers to perform human studies prior to, and sometimes in place of, human clinical trials in order to predict drug outcomes. Representatives of the
Article Details
BioPharm International
eBook: Regulatory Sourcebook
March 2021
Pages: 27–30
Citation
When referring to this article, please cite it as H. Einolf, et al., " Enabling the Virtual Human Through Physiologically-based Pharmacokinetic Modeling," BioPharm International Regulatory Sourcebook eBook (March 2021).
Articles in this issue
over 4 years ago
It Takes a Bio/Pharma Villageover 4 years ago
Collaborative Efforts Address Key Data Integrity Challengesover 4 years ago
Can FDA Reinvent Inspections?over 4 years ago
Growing Pipeline of Antisense Oligonucleotides Prompts Guidanceover 4 years ago
Gene Therapies Target Neurodegenerative Diseasesover 4 years ago
A Real-World Approach to Evaluating Cleanroom Garmentsover 4 years ago
FDA 2021 Guidance Agenda Sees Focus on Genericsover 4 years ago
Regulatory and Standard Setting Organizations DirectoryNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.